The Global Excipients Industry is Expected to Reach USD 7,586.6 Million in 2018: Transparency Market Research

According to a new market report published by Transparency Market Research "Excipients Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018," the global excipients demand was worth USD 5,260.0 million in 2011 and is expected to reach USD 7,586.6 million in 2018, growing at a CAGR of 5.4% from 2013 to 2018. Currently, Europe dominates the global market in terms of demand; however Asia Pacific is expected to be the most promising market in the near future mainly due to the availability of low cost products and cheap labor. The North America market for excipients in terms of revenue is growing at a CAGR of 5.3% from 2013 to 2018 as the U.S. has the biggest pharmaceutical market globally.

The demand for excipients is witnessing significant growth as it is considered as the functional additive in the pharmaceutical industry. Some of the factors driving the growth of the excipients market include increasing demand for novel excipients and growth in the global pharmaceuticals market. However, the market is being restrained due to the high cost of manufacturing, supply chain issues, and declining R&D investment.

Brows Full Report at: 

http://www.transparencymarketresearch.com/excipients-market.html

In terms of products, the market is dominated by sugar and other applications which are primarily driven by its uses as fillers, diluents and tablet coating agents. The market for sugar and other products in terms of volumes is expected to grow at a CAGR of 5.1% from 2013 to 2018. Following sugar and other products, the market for alcohol and gelatin are also growing significantly.

In respect to excipients market by type, pregelatinized starch is expected to grow with the highest CAGR of 6.2% from 2013 to 2018 in terms of revenue and in terms of volumes the market for glycerin is growing with the highest CAGR of 6.4% from 2013 to 2018. The growth of gelatins is driven by its growing use in manufacturing drug capsules.

Some of the major players of the market include BASF, DOW, ADM, ABF, FMC, Evonik, Cargill, Proctor and Gamble and Akzonobel.

This research is specially designed to estimate and analyze the demand and performance of excipients in a global scenario. The research provides in-depth analysis of excipients manufacturers, product sales, and trend analysis by segments and demand by geography. The report covers all the major product segments of the excipients market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. 

In addition the report provides cross-sectional analysis of all the above segments with respect to the following geographical markets:

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: +1-866-552-3453

Email: sales@transparencymarketresearch.com

Brows Full Report with TOC at: 

http://www.transparencymarketresearch.com/excipients-market.html

Global Phytosterols Market is Expected to Cross USD 887.8 million in 2018: Transparency Market Research

According to a new market report published by Transparency Market Research "Phytosterols Market (β-Sitosterol, Campesterol, Stigmasterol, Ergosterol) - Global Industry Analysis, Market Size, Share, Growth and Forecast, 2010 - 2018," the global market for phytosterols was estimated to be worth over USD 391.5 million in 2010 and is expected to cross USD 887.8 million by 2018, growing at a CAGR of over 9.5% from 2013 to 2018. Europe is the biggest market for phytosterols, accounting for approximately 51% of the global market in 2011, followed by North America. The favorable regulatory condition in the western world is propelling the growth of this market in the region.

Beta-sitosterol is the most widely consumed phytosterol, accounting for 65% of total phytosterols consumed. Campesterol emerged as the second biggest phytosterol consumed next to beta-sitosterol. Other phytosterols include stigmasterol and ergosterol. One of the key factors driving the growth of the Global Phytosterols Market is growing incidence of heart diseases which accounts for approximately 50% of the total deaths in industrialized countries. The regulatory approval for cholesterol reducing properties contained in phytosterols is also helping the overall market to grow.    

Browse the full report at: 

http://www.transparencymarketresearch.com/phytosterols-market.html  

However, confusion in the consumer's mind arising due to difficulty in differentiating phytosterols and other heart related healthy food is acting as one of the major factor which is restraining the overall market. Lack of awareness about the benefits among young people is hampering the market.  

Huge opportunities exist in the Asia Pacific market which is offering cheap phytosterols ingredients. This poses a constant threat to the Western markets. So the road ahead to maintain market share opportunities lies in forming partnerships and collaborations with Asian companies. Incorporation of phytosterols in new food products also holds the edge to the growth of the overall market in the near future.  

Food ingredients including supplements and beverages emerged as the biggest application segment for phytosterols. Food ingredients accounted for approximately 51% of the market in 2011. Pharmaceuticals are the next biggest application segment for phytosterols, followed by cosmetics.

Some of the major players in the phytosterols market include Cognis-BASF, PhytoSource L.P, ADM, Raisio Life Sciences and Forbes Meditech among other companies.

This research is specially designed to estimate and analyze the demand and performance of phytosterols in a global scenario. The research provides in-depth analysis of phytosterols manufacturers, trend analysis by segments and demand by geography. The report covers all the major segments of the global phytosterols market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents comprehensive assessment of the stakeholder strategies winning imperatives for them by segmenting the global phytosterols market as below:

Phytosterols Market, by Product Types:

- Beta-sitosterol

- Campesterol

- Stigmasterol

- Ergosterol

Phytosterols Market, by Applications:

- Food Ingredients (including supplements and beverages)

- Pharmaceuticals

- Cosmetics

The report provides a cross-sectional analysis of all the above segments with respect to the following geographical markets:

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Browse the full report at: 

http://www.transparencymarketresearch.com/phytosterols-market.html  

Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market is Expected to Reach USD 17.5 billion in 2018: Transparency Market Research

According to a new market report published by Transparency Market Research "High Potency Active Pharmaceutical Ingredients (HPAPIs) Market - Global Scenario, Trends, Industry Analysis, Size, Share & Forecast, 2012 - 2018," the global HPAPI market was worth USD 9.1 billion in 2011 and is expected to reach USD 17.5 billion in 2018, growing at a CAGR of 9.9% from 2012 to 2018. In the overall global market, North America accounts for the largest market share, whereas Asia Pacific is likely to witness highest growth in the forecasted period. India and China will be the major countries to register high growth rate in the high potency active pharmaceutical ingredients (HPAPIs) market due to rising health awareness, growing economies and improving healthcare systems.

Browse the full report at: 

http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html  

High potency active pharmaceutical ingredients (HPAPIs) are growing rapidly as compared to other segments of the healthcare industry. HPAPI are the compounds helpful in the treatment of respiratory disorders, treatment of cancer and hormonal imbalances. Growing oncology therapeutics market worldwide is the key factor driving the growth of this market.

High Potency Active Pharmaceutical Ingredients Market is a growing concept and is considered to be a boost to the pharmaceutical industry. Patented high potency drug development majorly dominates the HPAPI market. The branded sector constitutes the major share of this market but the patents of this branded sector are expected to expire in the coming few years that will help HPAPI manufacturers to cater to multiple clients by producing the generic version of the ingredients in bulk.

Some of the factors driving this market at a rapid growth rate are majority of blockbuster drugs nearing patent expiry, US government promoting generic drugs to reduce its medical burden, insurance companies preferring generic drugs over patented drugs for cost effectiveness and India and China with maximum DMFs with the US FDA.

However, a large number of competitors are entering this market making it highly fragmented which may slow down the growth of this market. Moreover, reduced R&D investments leading to low demand of HPAPIs and shortage of US FDA approved manufacturing sites are also likely to be the major restraints for the growth of the high potency active pharmaceutical ingredients market.

However, North America has been the largest market for high potency pharmaceutical ingredients as the country spends highly on the development of healthcare systems, whereas the European market has experienced several fluctuations in the past few years but is expected to grow rapidly in the near future due to rise in the demand of oncology drugs in this region.

Asia Pacific region is expected to witness high growth in the coming years due to the production of generics at a significant rate. Currently, the Asia Pacific region is the second largest market after North America for HPAPIs and is expected to become the largest market soon. Skilled manpower and low labor cost are greatly contributing to API manufacturing and outsourcing combined with research and development. India and China are the major countries in the Asia Pacific region expected to witness high growth in the near future.

Some of the major players of this market are Pfizer, Roche, Novartis, GlaxoSmithkline Pharmaceuticals Ltd., BASF Se, Hospira Inc., Matrix Laboratories Limited, Covidein Plc and Astra Geneca International, among others.

This research is specially designed to estimate and analyze the demand and performance of high potency active pharmaceutical ingredients in a global scenario. The research provides in-depth analysis of the HPAPI market by end use, by application and by type segments and demand by geography. The report covers all the major product segments of the High HPAPIs market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies winning imperatives for them by segmenting the HPAPI market as below:

• HPAPI Market, 2012 - 2018
  • Introduction  
  • HPAPI Classification as per Safebridge Consultants  
  • Overview: HPAPI Global Market  
  • Manufacturing Capabilities  
    • Handling requirements  
    • Personnel considerations  
    • Plant & equipment  
    • Technology
• HPAPI Market, By Type of Synthesis, 2012 - 2018
  • Overview  
  • Sub-Segments Of HPAPI Market
  • By Type Of Synthesis  
    • Synthetic HPAPI
    • Biotech HPAPI
  • By Type of Manufacturers  
    • Captive or In-house manufacturers
    • Merchant or Third party manufacturers
  • By Type of Market  
    • Innovative  
    • Generic

In addition the report provides a cross-sectional analysis of all the above segments with respect to the following geographical markets:

• North America
• Europe
• Asia
• RoW

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Browse the full report with TOC at: 

http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html  

Global Neuromodulation Devices Market is Expected to Reach USD 7,072.6 Million in 2018: Transparency Market Research

According to a new market report published by Transparency Market Research "Neuromodulation Devices Market - Global Industry Analysis, Size, Share and Forecast, 2012 - 2018," the global neuromodulation devices market was valued at USD 2,758 million in 2011 and is expected to grow at a CAGR of 14.4% from 2012 to 2018, to reach an estimated value of USD 7,072.6 million by 2018.

The market is driven by factors such as the aging world population leading to chronic diseases such as Parkinson's and Alzheimer's disorders and technological advancements in the field of neuromodulation devices including the invention of transdermal neuromodulation technology by NMT (Neurowave Medical Technologies). Moreover, the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, the availability of external funding to conduct clinical studies to help come up with new and technologically advanced products and the rising healthcare related consumer expenditure have also driven the growth in this market. 

Browse the full report at: 

http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html

The fact that a neuromodulation device could be used as an add-on treatment and so can be used simultaneously with other medications also drives the market forward.

The North American region holds majority of the market share and accounted for a share of 65% in 2011. The North American neuromodulation device market was valued at USD 1,792.7 million in 2011. The economic developments in the Asia Pacific region make it the fastest growing region (CAGR of more than 15% from 2012 to 2018) in the neuromodulation devices market.

The future growth of the market will be ensured by capitalizing on market opportunities such as increasing healthcare related consumer expenditure in emerging economies in the Asia Pacific, Latin American and Eastern European regions. The availability of medical device manufacturing outsourcing options helps in curbing costs and thereby enhances profit margins. Also, the presence of consolidation options in the healthcare industry helps in strengthening the revenue base to conduct R&D exercises for new product development and thus helps in strengthening market share.

Implementation of the Affordable Healthcare for America Act, 2010 which imposes an excise tax of 2.5% on medical devices and the stringent FDA regulations are some of the factors restraining the growth of the market. Risks involved in using a neuromodulation device such as injury to the vagus nerve and nearby blood vessels (carotid artery and jugular vein) in case of a vagus nerve pacemaker also impedes the growth of the market.

·         Neuromodulation Devices Market by Technology

·         Spinal Cord Stimulation Devices

·         Deep Brain Stimulation Devices

·         Vagus Nerve Stimulation Devices

·         Sacral Nerve Stimulation Devices

·         Gastric Electric Stimulation Devices

·         Neuromodulation Systems for Different Application Areas

·         Medtronic's Spinal Cord and Deep Brain Neurostimulation Systems

·         St. Jude Medical's Eon  Mini Neurostimulator System

·         Boston Scientific's Precision Spinal Cord Stimulation System

·         Nevro's Senza System for Spinal Cord Stimulation

·         Cyberonics' VNS Therapy System

·         Codman & Shurtleff's Medstream system

·         Medtronic's Enterra™ Therapy System

·         IntraPace's abiliti system

·         Neuromodulation Devices Market by Geography

·         North America

·         Europe

·         Asia Pacific

·         RoW (Rest of the World)

Browse the full report at: 

http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html

Global Soy and Milk Protein Ingredients Market (Concentrates, Isolates & Hydrolysates) - Industry Analysis, Market Size, Share, Growth And Forecast, 2010 - 2018

According to a new market report published by Transparency Market Research "Global Soy & Milk Protein Ingredients Market (Concentrates, Isolates & Hydrolysates) - Industry Analysis, Market Size, Share, Growth and Forecast, 2010 - 2018," the global market for soy and milk protein ingredients was estimated to be worth USD 8,500 million in 2010 and is expected to cross USD 13,000 million in 2018, growing at a CAGR of over 6% from 2013 to 2018. In the overall global market, Europe is the largest consumer of soy proteins; however Asia Pacific is expected to be the most promising market in the near future.

The market for soy protein is mainly driven due to health benefits associated with it, better and economical source of high quality proteins and its functional properties. However, negative impact of genetically modified (GM) soy and the challenging environment of the protein industry including milk proteins, pea proteins and other animal proteins can prove to be the major barriers of the market. Europe and North America are the largest but saturated markets, whereas growth is expected to be robust in the economies of Asia Pacific. China, Brazil and India are expected to be the most attractive markets in the next six years.

Browse For Full report at: 

http://www.transparencymarketresearch.com/soy-and-milk-protein-ingredients-market.html

Asia is the largest consumer of soy flour, isolated soy proteins and soy protein concentrates. Themarket for milk protein ingredients is growing continuously in terms of revenues due to the increasing population and the high standard of living, the major factors driving the growth of the market. Moreover, due to increasing consumer awareness about the adverse effects of animal protein, the market is shifting towards plant and milk proteins. Milk protein concentrates due to their usage flexibility and low cost are replacing the market for dairy products. Asia Pacific has the highest number of consumers of milk ingredients.

While milk proteins are dominated by caseins, caseinates and concentrates, the soy protein market is dominated by protein concentrates and isolates. This market research study analyzes the current and future market potential for soy and milk protein isolates, concentrates and hydrolysates in terms of applications, price trends and product specifications.

Some of the major players of the market are Dupont, ADM, Armor Proteins, Bunge Alimentos SA, Burcon NutraScience, Cargill Health & Food Technologies, Dean Foods Company, Gelita Group, Doves Farm Foods, DuPont Agriculture & Nutrition, George Weston Foods, Kellogg Company,Kerry Ingredients Inc., Kraft Foods, Manildra Group, MGP Ingredients, Omega Protein Corporation and so on.

This research is specially designed to estimate and analyze the demand and performance of soy and milk protein ingredients in a global scenario. The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the soy and milk protein ingredients market as below:

• Soy protein ingredients market, by types
  • Soy Protein Isolates
  • Soy Protein Concentrates
  • Soy Flours
  • Others

• Soy protein ingredients market, by applications
  • Bakery & Confectionary
  • Meat Alternatives
  • Functional Foods
  • Dairy Replacement
  • Infant Foods
  • Others

• Milk protein ingredients market, by types
  • Total Milk Protein Products
  • Casein Products
  • Whey Products
  • Skimmed milk powder
  • Other

In addition the report provides a cross-sectional analysis of all the above segments with respect to the following geographical markets:

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with a highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

http://www.transparencymarketresearch.com

Browse For Full report at: 

http://www.transparencymarketresearch.com/soy-and-milk-protein-ingredients-market.html

Preimplantation Genetic Diagnosis (PGD) Market is Expected to Reach USD 47.4 Million Globally in 2018: Transparency Market Research

According to the latest market report published by Transparency Market Research "Preimplantation Genetic Diagnosis (PGD) Market - Global Industry Analysis, Market Size, Market Share & Forecast 2012 - 2018," the global pre-implantation genetic diagnosis market was estimated to be worth USD 31.9 million in 2011 and is expected to reach USD 47.4 million in 2018, growing at a CAGR of 6.2% from 2013 to 2018. North America dominates the global demand for PGD, and is expected to account for over 30% of the global market followed by Europe at 28% in 2018.

Some of the major drivers of the global PGD market are increase in the scope of direct to consumer genetic testing methods, increase in the number of cases of genetic diseases, the rising rate of infertility and the efficiency of PGD in assisting successful fetal implantation.  PGD is adjunct to in vitro fertilization (IVF) and is employed for detection of any genetic abnormality in the embryo before it is implanted through IVF.

Browse For Full Report at: 
http://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html

The major types of PGD testing are for determination of chromosomal abnormalities, detection of aneuploidy, HLA typing, gender selection and others. The major market for PGD exists in developed countries. However, emerging markets in the developing nations of Asia and rest of the world will grow with the advent of genetic diagnosis technology and awareness about prevention of genetic disorders.

Over the last decade, the demand for PGD has grown significantly, mostly owing to the growing awareness regarding the prevention of genetic diseases and the increase in the number of genetic disorders which can be diagnosed through PGD. Major opportunities which can be tapped for inducing further growth of the PGD market are innovations in the field of diagnosis of genetically inherited cancer and innovations in genetic diagnosis.The prime geographical markets for PGD are Europe and North America. It is expected that North America will lead the PGD market in terms of market share and revenue by 2018. Asia and rest of the world will also grow at a fast yet steady pace and make their mark in the global PGD market.

This research is specially designed to estimate and analyze the demand for preimplantation genetic diagnosis in the global market. The research provides in-depth analysis of preimplantation genetic diagnosis service providers, the product sales, segment wise trend analysis and the demand of PGD by geography. High level analysis of the segments of the global PGD market is performed and the report provides detailed analysis, comprehensive historical data and statistically tested forecast of the segments thus covered. A comprehensive assessment of the strategies of the participants of the market and the winning imperatives for them has been analyzed by segmenting the global preimplantation genetic diagnosis market.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, 
Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453 
Email: sales@transparencymarketresearch.com

Browse For Full Report with TOC at: 

http://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html

Global ECG Monitoring Systems Market is Expected to Reach USD 822.1 Million in 2016: Transparency Market Research

According to a new market report published by Transparency Market Research "ECG Monitoring Systems Market - Global Industry Analysis by Type, Size, Share and Forecast, 2011 - 2016," the global ECG monitoring systems market is estimated to reach a market size worth USD 822.1 million in 2016, growing at a CAGR of 7.6% from 2011 to 2016. The total shipment of overall ECG monitoring systems is expected to grow from 262.1 thousand units in 2011 to 374.8 thousand units in 2016 with a CAGR of 7.4% during the same period. Rest ECG monitoring systems dominated the overall market both in terms of shipment and revenue in 2011, while stress ECG monitoring systems had highest selling price.

It is estimated that cardiovascular diseases are the largest cause of deaths globally - around 17.3 million people died from cardiovascular diseases (CVD) in 2008. This amounts to about 32.8% of all deaths. Of these deaths, an estimated 7.3 million were due to coronary heart disease and 6.2 million were due to stroke. 

Browse the full report at: 

http://www.transparencymarketresearch.com/ecg-monitoring-systems-market.html 

The number of total deaths due to cardiovascular diseases is expected to rise to 18.3 million in 2012 and 20.5 million by 2020. Low - and middle-income countries are the largest affected with CVDs. An estimated 80% of CVD deaths take place in these low- and middle-income countries. By 2030, almost 23.6 million people will die from CVDs, mainly from heart disease and stroke, projected to be the single leading causes of death.

The growth in cardiovascular fatalities, increasing number of cardiovascular cases, growing health consciousness, and increasing per capita healthcare expenditure are some of the major drivers for the growth of the ECG monitoring systems market. In addition, growing prescription to test ratio is also boosting the market growth. In the U.S., the total number of holter monitor tests is expected to grow at a CAGR of 8.9% from 2011 to 2016. On the other hand, event monitor tests in the U.S. are expected to grow at CAGR of 3.1% during the same period.

The U.S. ECG monitoring systems market is the largest in the world with revenue of USD 197.8 million in 2011. The total shipment of ECG monitoring systems in the U.S. is expected to rise to 94.6 thousand units in 2016. Germany is the second largest market for ECG monitoring systems with revenue of USD 54.9 million in 2011.

Rest ECG Monitoring Systems

• Stress ECG Monitoring Systems
• Holter Monitoring Systems
• Event Monitoring Systems

Countries Covered

• U.S.
• Canada
• U.K.
• France
• Italy
• Germany
• Spain
• Japan
• India
• China
• Australia
• Brazil

Market Data

• Volume
• Revenue
• Price
• Average Number of Tests Performed per Year
• Market Share of Major Players by Segment
• Channel Analysis and ROI Consideration
• Distribution Channels
• Break-even Analysis

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Search Reports: http://www.mrrse.com/

Podcast: http://transparencymarketresearch.podbean.com/

Browse the full report with TOC at: 

http://www.transparencymarketresearch.com/ecg-monitoring-systems-market.html